Eli Lilly reserves $470M for new manufacturing plant — and North Carolina is more than pleased

Amber Tong

Eli Lilly is adding an eighth site to its network of manufacturing plants in the US, investing $470 million to begin production of injectable products …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Eli Lilly reserves $470M for new manufacturing plant — and North Carolina is more than pleased

Amber Tong

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Updated: To spin off or not to spin off? Galapagos backpedals on separation plans, CEO Paul Stoffels exits early

Bayer starts 2025 by cutting 2,000 jobs as it homes in on year-end rehaul target

Dutch biotech gets $146M for late-stage trials in three metabolic disorders

TIGIT graveyard expands as GSK drops late-stage asset with iTeos

Arcturus to prioritize mRNA therapeutics in bid to boost rare disease programs

UnitedHealth Group CEO Andrew Witty steps down

Eli Lil­ly re­serves $470M for new man­u­fac­tur­ing plant — and North Car­oli­na is more than pleased

Sign up to read this article for free.

more like this

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Eli Lilly reserves $470M for new manufacturing plant — and North Carolina is more than pleased